Editorial use only.
Memantine Alzheimer's disease drug. Box containing tablets of the Alzheimer's disease drug memantine hydrochloride, marketed under the name Memantine Mylan. Memantine helps relieve the symptoms of moderate-to-severe Alzheimer's disease by acting on the glutamatergic system through blocking NMDA-type glutamate receptors in the brain. However, it has been shown to have little effect in mild forms of the disease.
Model release available. Property release not required.